Does TRICARE Cover Ketamine Treatment? What Military Families in Hampton Roads Should Know

Last modified July 24, 2026

unsplash image - military family considering TRICARE ketamine treatment in Hampton Roads

Written by Deborah Tan
Medically reviewed by Dr. Ladan Eshkevari, CRNA, PhD, FAAN

Does TRICARE cover ketamine treatment? Only partly. As of July 2026, TRICARE covers Spravato (esketamine) nasal spray for specific depression diagnoses, but it does not cover IV ketamine for mental health.[1] If you are stationed in Hampton Roads, our Norfolk veterans page covers local care, and this guide walks through the three realistic ways to pay.

Key takeaways

  • TRICARE covers Spravato, not IV ketamine: Spravato is a limited benefit for treatment-resistant depression and major depressive disorder with suicidal ideation or behavior, with prior authorization. IV ketamine for mental health is not a covered benefit as of July 2026.[1][2]
  • Eligible veterans can pay nothing: through VA community care, the VA can authorize both IV ketamine and Spravato at our Norfolk clinic at no cost to the veteran.[9]
  • Self-pay IV ketamine is $450 per infusion with us, $425 for veterans: a standard six-infusion induction series runs $2,700, or $2,550 at the veteran rate, below the $3,000 to $5,000 national range for an initial course.[4]
  • Your plan shapes your out-of-network choices: TRICARE Select members can see non-network providers and pay cost shares. Prime generally cannot without a referral or the point-of-service option.[3]

What TRICARE Does and Does Not Cover

Here is the honest answer up front. TRICARE covers Spravato (esketamine) as a limited benefit for adults 18 and older with treatment-resistant depression, meaning depression that has not improved after two or more adequate trials of antidepressant medication.[2][8] Coverage also extends to major depressive disorder with suicidal ideation or behavior.[2] Every case requires prior authorization, and treatment must happen at a clinic certified under the FDA’s REMS safety program.[2] PTSD alone does not qualify under current policy.

IV ketamine is a different story. The FDA approved ketamine as an anesthetic, so its use for depression, anxiety, and PTSD is off-label, and TRICARE’s contractors state plainly that ketamine given by IV, injection, or other routes is “not a covered benefit” for mental health.[1] That is the wall many military families hit: the form of ketamine treatment with the longest clinical track record for treatment-resistant depression is the one TRICARE will not pay for.

One more thing we would rather say now than after a billing surprise: we are not in network with TRICARE. What follows are the three routes that actually work, and one of them is free.

infographic comparing three ways military families pay for ketamine treatment: free VA community care for eligible veterans, Spravato covered through TRICARE with prior authorization, and self-pay IV ketamine at $450 per infusion or $425 for veterans

Route 1: VA Community Care, Free for Eligible Veterans

If you are a veteran enrolled in VA health care and you have treatment-resistant depression, the VA can authorize ketamine treatment at our clinic through community care, and you pay nothing. That authorization covers both IV ketamine and Spravato.[9] We handle the paperwork with the VA directly.

The referral process has its own steps and timelines, and we wrote a full explainer: how VA community care works for ketamine treatment.

The boundary matters, though. Community care is a VA benefit for veterans. Active-duty service members and family members on TRICARE are not eligible for this route, which is why the next two exist.

Route 2: Spravato Through TRICARE

If your diagnosis fits, Spravato is a real path to staying in network. The sequence looks like this: your provider documents treatment-resistant depression or major depressive disorder with suicidal ideation, submits a prior authorization request, and treatment begins at a REMS-certified clinic, where you stay for about two hours of monitoring after each dose.[2][6]

We will say something here that most clinics will not: if Spravato fits your diagnosis and cost is your top concern, an in-network Spravato clinic is your least expensive choice, even if that clinic is not us. You have earned care that is chosen for your situation, not for a clinic’s revenue.

Tricare rules have exceptions, so confirm your specific plan’s terms with Humana Military, the East Region contractor for Virginia, before booking anywhere.

For scale: without insurance, the Spravato medication alone lists at roughly $800 for a 56 mg dose and $1,200 for 84 mg.[7] Plan for monitoring fees on top of the medication cost, too. That portion is billed by the clinic, varies from clinic to clinic, and depends on whether the clinic is in network. The numbers are why the prior authorization is worth the paperwork.

What Does Ketamine Treatment Cost for Military Families?

clinician monitoring a veteran during a 40 to 60 minute IV ketamine infusion at our Norfolk clinic

If TRICARE will not cover IV ketamine and Community Care does not apply to you, route 3 is self-pay. We publish our prices because guessing at a bill is its own kind of stress.

Our self-pay price for IV ketamine is $450 per infusion, the same at Norfolk as at all five of our clinics, and veterans pay a discounted $425 per infusion. Each infusion is a 40 to 60 minute monitored session with a clinician tracking your vital signs the entire time. A standard induction series is six infusions over two to three weeks, which puts the full series at $2,700, or $2,550 at the veteran rate.

For context, the American Society of Ketamine Physicians, Psychotherapists and Practitioners puts a reasonable price at $400 to $800 per infusion, with initial treatment courses nationally running $3,000 to $5,000.[4] Our full series comes in under the low end of that national range. If you want the complete national picture across IV, nasal, and oral forms, see our guide to how much ketamine therapy costs.

For Spravato at our clinics, self-pay works differently: when your insurance covers the medication itself, the out-of-pocket office visit for monitored administration is $250 per session.

What are you paying for at $425? Monitored, in-clinic ketamine care: a clinician at your side, blood pressure and vitals tracked through the full infusion, and protocols aligned with the 2018 multi-society consensus guidelines on IV ketamine developed by ASRA, AAPM, and ASA.[5] Ketamine therapy without insurance is a real expense. Unmonitored shortcuts are the wrong place to save.

Is It Worth It? What the Research Shows

The research case for ketamine in treatment-resistant depression starts with a 2006 NIMH randomized trial: 71 percent of subjects who received a single IV ketamine infusion met response criteria the following day.[10] In our own outcome tracking across mood disorders, 68 to 70 percent of patients respond, as of 2026. Ketamine therapy for veterans and military families carries the same evidence base, including for the depression that often travels with PTSD.

Honesty matters more than optimism here. These numbers describe responders, and not everyone responds. Ketamine is not a cure, some patients feel little change, and responders typically need periodic maintenance to hold their gains. What we can do is screen carefully before you spend anything, and tell you plainly if we think ketamine is not your best next step.

FAQ: TRICARE, Ketamine, and Cost

Does TRICARE cover Spravato?

Yes. TRICARE covers Spravato (esketamine) for adults 18 and older with treatment-resistant depression or major depressive disorder with suicidal ideation or behavior. Prior authorization is required for every beneficiary, and the clinic must be REMS-certified. PTSD by itself is not a qualifying diagnosis under current policy.[2]

Does TRICARE cover ketamine infusions?

Generally, no. IV ketamine is FDA-approved as an anesthetic, so mental health treatment with it is off-label, and TRICARE excludes ketamine by IV and other routes from coverage for these conditions.[1] Spravato, which is FDA-approved for specific depression diagnoses, is the exception.

How much does ketamine therapy cost without insurance?

Our self-pay price is $450 per IV infusion ($425 for veterans), or $2,700 for a standard six-infusion induction series ($2,550 at the veteran rate). Nationally, infusions typically run $400 to $800 each, with initial courses between $3,000 and $5,000.[4] Spravato medication alone lists near $800 to $1,200 per dose without coverage.[7]

Can I use VA community care instead of TRICARE?

Veterans enrolled in VA health care can, with a VA authorization, and treatment is free for them at our clinic. Active-duty service members and TRICARE family members cannot use this route. Our community care explainer covers eligibility and referral steps.

I have PTSD. What are my options?

TRICARE does not cover Spravato for PTSD alone. Many people with PTSD also meet criteria for treatment-resistant depression, and that diagnosis can open the Spravato route. If you have PTSD without treatment-resistant depression, the usual path is off-label IV ketamine on a self-pay basis; our guide to ketamine for PTSD covers the evidence and what to expect. A free consult can sort out which diagnoses apply and which route fits. We treat adults 18 and older.

Not sure which of the three routes fits your situation? Schedule a free telehealth consult and we will walk through VA community care, TRICARE, and self-pay with you before you commit to anything. Or call (301) 381-8381 and mention you are interested in the Norfolk clinic.

Graphic offering a free consultation with Avesta Ketamine and Wellness in DC Virginia and Maryland

References

  1. Health Net Federal Services. “Spravato Nasal Spray.” TRICARE West Benefits A to Z. Accessed July 23, 2026.
  2. TriWest Healthcare Alliance. “TRICARE Behavioral Health Coverage and Requirements.” June 10, 2025. Accessed July 23, 2026.
  3. TRICARE. “Non-Network Providers.” TRICARE.mil, last updated April 21, 2026. Accessed July 23, 2026.
  4. American Society of Ketamine Physicians, Psychotherapists and Practitioners. “Is Ketamine Right for You?” ASKP3. Accessed July 23, 2026.
  5. Cohen SP, Bhatia A, Buvanendran A, et al. “Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.” Regional Anesthesia and Pain Medicine, 2018;43(5):456-466. Accessed July 23, 2026.
  6. Johnson & Johnson. “SPRAVATO (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression.” January 21, 2025. Accessed July 23, 2026.
  7. Drugs.com. “Spravato Prices, Coupons and Patient Assistance Programs.” Accessed July 23, 2026.
  8. Defense Health Agency. “Esketamine for Major Depressive Disorder.” Health.mil, April 27, 2021. Accessed July 23, 2026.
  9. U.S. Department of Veterans Affairs. “Intravenous Ketamine for Treatment Resistant Depression.” Community Care Delivery Instruction CDI 00030. Accessed July 23, 2026.
  10. Zarate CA Jr, Singh JB, Carlson PJ, et al. “A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression.” Archives of General Psychiatry, 2006;63(8):856-864. Accessed July 23, 2026.

Deborah is co-CEO of Avesta Ketamine and Wellness. She is dedicated to improving the patient experience and to expanding access for cutting-edge mental health treatments for patients suffering from treatment-resistant depression, generalized anxiety, PTSD and other mood disorders.

Start Your Wellness Journey

Take the first step to healing. Speak with one of our experienced intake coordinators to: